Brazil Study Suggests AstraZeneca Vaccine Is Effective Against Brazil COVID-19 Variant

Preliminary studies suggest the AstraZenca vaccine will protect against the P1 variant of the coronavirus, Mauricio Zuma, the head of production at Brazil’s Fiocruz biomedical institute said on Monday, confirming a Reuters report on Friday.

The Brazil variant is worrying experts because it is highly contagious and has led several countries to ban travel from Latin American nation. 


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s